LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Product Portfolio Pear Therapeutics has a diverse portfolio of prescription digital therapeutics with FDA approvals for treating substance use disorder, opioid use disorder, and chronic insomnia, providing a unique opportunity to target healthcare providers looking for cutting-edge solutions to address patient needs.

Recent Acquisitions Through the acquisition of companies like Mindstrong Health, Pear Therapeutics has expanded its offerings in digital therapeutics for mental health conditions. This presents an opportunity to approach mental health institutions and professionals seeking comprehensive digital solutions to enhance patient care.

Strategic Partnerships With a history of collaboration, such as merging with SPAC Thimble Point Acquisition, Pear Therapeutics has demonstrated a commitment to strategic partnerships. Sales development representatives can leverage these partnerships to explore new market verticals and engage with potential clients through shared networks.

Financial Stability Despite past financial challenges, Pear Therapeutics' revenue ranging from $50M to $100M and funding of $125M signals financial stability. This financial health provides an opportunity for business development professionals to engage in long-term partnerships with a reliable and well-funded company.

Competitive Positioning Being a leader in software-based medicines, Pear Therapeutics competes with major biotech companies like Novartis, Pfizer, and Johnson & Johnson. Sales development representatives can capitalize on Pear's innovative offerings to differentiate and position the company as a valuable partner in the competitive healthcare market.

Similar companies to Pear Therapeutics

Pear Therapeutics Tech Stack

Pear Therapeutics uses 8 technology products and services including SAS, Sisense, PostgreSQL, and more. Explore Pear Therapeutics's tech stack below.

  • SAS
    Business Intelligence
  • Sisense
    Business Intelligence
  • PostgreSQL
    Database
  • Font Awesome
    Font Scripts
  • Okta
    Identity Verification
  • FancyBox
    Javascript Libraries
  • Ruby
    Programming Languages
  • C++
    Programming Languages

Media & News

Pear Therapeutics's Email Address Formats

Pear Therapeutics uses at least 1 format(s):
Pear Therapeutics Email FormatsExamplePercentage
First.Last@peartherapeutics.comJohn.Doe@peartherapeutics.com
92%
First-Last@peartherapeutics.comJohn-Doe@peartherapeutics.com
5%
FirstL@peartherapeutics.comJohnD@peartherapeutics.com
2%
FLast@peartherapeutics.comJDoe@peartherapeutics.com
1%

Frequently Asked Questions

Where is Pear Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Pear Therapeutics's main headquarters is located at 200 State St Boston, Massachusetts 02109 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Pear Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Pear Therapeutics's main corporate office by phone at +1-646-932-2774. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Pear Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Pear Therapeutics is a publicly traded company; the company's stock symbol is PEARQ.

What is Pear Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Pear Therapeutics's official website is peartherapeutics.com and has social profiles on LinkedIn.

How much revenue does Pear Therapeutics generate?

Minus sign iconPlus sign icon
As of May 2024, Pear Therapeutics's annual revenue reached $75M.

What is Pear Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Pear Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Pear Therapeutics have currently?

Minus sign iconPlus sign icon
As of May 2024, Pear Therapeutics has approximately 201 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Intellectual Property Counsel And Associate General Counsel: J. C.Vice President Corporate Communications: A. G.Vice President Product: G. H.. Explore Pear Therapeutics's employee directory with LeadIQ.

What industry does Pear Therapeutics belong to?

Minus sign iconPlus sign icon
Pear Therapeutics operates in the Biotechnology Research industry.

What technology does Pear Therapeutics use?

Minus sign iconPlus sign icon
Pear Therapeutics's tech stack includes SASSisensePostgreSQLFont AwesomeOktaFancyBoxRubyC++.

What is Pear Therapeutics's email format?

Minus sign iconPlus sign icon
Pear Therapeutics's email format typically follows the pattern of . Find more Pear Therapeutics email formats with LeadIQ.

How much funding has Pear Therapeutics raised to date?

Minus sign iconPlus sign icon
As of May 2024, Pear Therapeutics has raised $125M in funding. The last funding round occurred on Dec 06, 2021 for $125M.

When was Pear Therapeutics founded?

Minus sign iconPlus sign icon
Pear Therapeutics was founded in 2013.
Pear Therapeutics

Pear Therapeutics

Biotechnology ResearchMassachusetts, United States201-500 Employees

Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs). Pear aims to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has the first end-to-end platform to discover, develop, and deliver PDTs to patients and a pipeline of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from the FDA. Pear’s product, reSET®, for the treatment of substance use disorder, was the first PDT to receive marketing authorization from the FDA to treat disease. Pear’s second product, reSET-O®, for the treatment of opioid use disorder, was the first PDT to receive Breakthrough Designation. Pear’s third product, Somryst® for the treatment of chronic insomnia, was the first PDT submitted through FDA’s traditional 510(k) pathway while simultaneously reviewed through FDA’s Software Precertification Pilot Program. For more information, visit Pear at www.peartherapeutics.com.

Section iconCompany Overview

Headquarters
200 State St Boston, Massachusetts 02109 US
Phone number
+1-646-932-2774
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
PEARQ
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
201-500

Section iconFunding & Financials

  • $125M

    Pear Therapeutics has raised a total of $125M of funding over 8 rounds. Their latest funding round was raised on Dec 06, 2021 in the amount of $125M.

  • $50M$100M

    Pear Therapeutics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $125M

    Pear Therapeutics has raised a total of $125M of funding over 8 rounds. Their latest funding round was raised on Dec 06, 2021 in the amount of $125M.

  • $50M$100M

    Pear Therapeutics's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.